792
Views
4
CrossRef citations to date
0
Altmetric
Perspectives on Rehabilitation

Barriers leading to increased disability in neurologically challenged populations during COVID-19 pandemic: a scoping review

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 7693-7706 | Received 10 Feb 2021, Accepted 24 Sep 2021, Published online: 19 Oct 2021

References

  • Wu F, Zhao S Feigin VL, Vos T, et al. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol. 2020;19(3):255–265.
  • Yu B, Chen YM, Wang W, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265–269.
  • WHO coronavirus disease (COVID-19) dashboard. Geneva: World Health Organization; 2020. Available from: https://covid19.who.int/
  • Bettger JP, Thoumi A, Marquevich V, De Groote W, et al. COVID-19: maintaining essential rehabilitation services across the care continuum. BMJ Glob Health. 2020;5(5):e002670.
  • Armitage R, Nellums LB. The COVID-19 response must be disability inclusive. Lancet Public Health. 2020;5(5):e257.
  • Krenzlin H, Bettag C, Rohde V, et al. Involuntary ambulatory triage during the COVID-19 pandemic – a neurosurgical perspective. PLOS One. 2020;15:1–7
  • Amukotuwa SA, Bammer R, Maingard J. Where have our patients gone? The impact of COVID-19 on stroke imaging and intervention at an Australian stroke center. J Med Imaging Radiat Oncol. 2020;64(5):607–614.
  • Prasad R, Lidhoo A, Lala T, et al. COVID-19 pandemic-related lockdown: effects on persons with disabilities in India. Apollo Med. 2020. DOI:10.4103/am.am_81_20.
  • Brown EG, Chahine LM, Goldman SM, et al. The effect of the COVID-19 pandemic on people with Parkinson's disease. J Parkinsons Dis. 2020;10(4):1365–1377.
  • Cohen G, Russo MJ, Campos JA, et al. COVID-19 epidemic in Argentina: worsening of behavioral symptoms in elderly subjects with dementia living in the community. Front Psychiatry. 2020;11:1–10.
  • Zanghì A, D'Amico E, Luca M, et al. Mental health status of relapsing-remitting multiple sclerosis Italian patients returning to work soon after the easing of lockdown during COVID-19 pandemic: a monocentric experience. Multiple Sclerosis Related Disorders. 2020;46:102561.
  • Ahmed ZM, Khalil MF, Kohail AM, et al. The prevalence and predictors of post-stroke depression and anxiety during COVID-19 pandemic. J Stroke Cerebrovasc Dis. 2020;29(12):105315.
  • Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.
  • Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5:69.
  • Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–473.
  • Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan – a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.
  • Bersano A, Kraemer M, Touzé E, et al. Stroke care during the COVID-19 pandemic: experience from three large European countries. Eur J Neurol. 2020;27(9):1794–1800.
  • Cohen IC. Treating dementia patients in the time of COVID [Internet]. Psychiatric Times. 2021. [cited 2 Oct 2021]. Available from: https://www.psychiatrictimes.com/view/treating-dementia-patients-time-covid.
  • Price J, Martin H, Ebenezer L. Caring for patients with Parkinson's disease during the covid-19 pandemic. J Commun Nurs. 2020;34(4).
  • Pandemic-driven mental health problems emerge in children presenting to ED [Internet]. Reliasmedia.com. 2021 [cited 2 Oct 2021]. Available from: https://www.reliasmedia.com/articles/146670-pandemic-driven-mental-health-problemsemerge-in-children-presenting-to-ed.
  • Müller P, Achraf A, Zou L, et al. COVID-19, physical (in) activity, and dementia prevention. Alzheimers Dement. 2020;6(1):e12091.
  • Ameis SH, Lai M-C, Mulsant BH, et al. Coping, fostering resilience, and driving care innovation for autistic people and their families during the COVID-19 pandemic and beyond. Mol Autism. 2020;11(1).
  • Granata T, Bisulli F, Arzimanoglou A, et al. Did the COVID-19 pandemic silence the needs of people with epilepsy? Epileptic Disord. 2020;22(4):439–442.
  • Ghoreishi A, Arsang-Jang S, Sabaa-Ayoun Z, et al. Stroke care trends during COVID-19 pandemic in Zanjan province, Iran. From the cascade initiative: statistical analysis plan and preliminary results. J Stroke Cerebrovasc Dis. 2020;29(12):105321.
  • Shalash A, Roushdy T, Essam M, et al. Mental health, physical activity, and quality of life in Parkinson's disease during COVID-19 pandemic. Mov Disord. 2020;35(7):1097–1099.
  • Costabile T, Carotenuto A, Lavorgna L, et al. COVID-19 pandemic and mental distress in multiple sclerosis: implications for clinical management. Eur J Neurol. 2021;28(10):3375–3383.
  • Dowlatshahi D, Stotts G, Bourgoin A, et al. Decreased stroke presentation rates at a comprehensive stroke center during COVID-19. Can J Neurol Sci. 2021;48(1:118–121.
  • Song J, Ahn JH, Choi I, et al. The changes of exercise pattern and clinical symptoms in patients with Parkinson's disease in the era of COVID-19 pandemic. Parkinsonism Relat Disord. 2020;80:148–151.
  • Huang JF, Greenway MR, Nasr DM, et al. Telestroke in the time of COVID-19: the Mayo Clinic experience. Mayo Clin Proc. 2020;95(8):1704–1708.
  • Reguera-García MM, Liébana-Presa C, Álvarez-Barrio L, et al. Physical activity, resilience, sense of coherence and coping in people with mumertalltiple sclerosis in the situation derived from COVID-19. IJERPH. 2020;17(21):8202.
  • Kumar N, Gupta R, Kumar H, et al. Impact of home confinement during COVID-19 pandemic on Parkinson's disease. Parkinsonism Related Disorders. 2020;80:32.
  • Patel PD, Kelly KA, Reynolds RA, et al. Tracking the volume of neurosurgical care during the coronavirus disease 2019 pandemic. World Neurosurgery. 2020;142:e183–e194.
  • Siegler JE, Heslin ME, Thau L, et al. Falling stroke rates during COVID- 19 pandemic at a comprehensive stroke center. J Stroke Cerebrovasc Dis. 2020;29(8):104953.
  • Villani ER, Vetrano DL, Damiano C, et al. Impact of COVID-19-Related lockdown on psychosocial, cognitive, and functional well-being in adults with down syndrome. Front Psychiatry. 2020;11:578686.
  • Piano C, Di Stasio E, Primiano G, et al. An Italian neurology outpatient clinic facing SARS-CoV-2 pandemic: data from 2,167 patients. Front Neurol. 2020;11:564.
  • Drum CE, Oberg A, Ditsch J, et al. COVID‐19 & adults with intellectual disability, autism, epilepsy, or brain injuries. Exceptional Parent. 2020;50:36–38.
  • Aguiar de Sousa D, van der Worp HB, Caso V, et al. Maintaining stroke care in Europe during the COVID-19 pandemic: results from an international survey of stroke professionals and practice recommendations from the European Stroke Organisation. Eur Stroke J. 2020;5(3):230–236.
  • Wirrell EC, Grinspan ZM, Knupp KG, et al. Care delivery for children with epilepsy during the COVID-19 pandemic: an international survey of clinicians. J Child Neurol. 2020;35(13):924–933.
  • Mauri E, Abati E, Musumeci O, et al. Estimating the impact of COVID-19 pandemic on services provided by Italian neuromuscular centers: an Italian association of myology survey of the acute phase. Acta Myol. 2020;39(2):57.
  • Zipprich HM, Teschner U, Witte OW, et al. Knowledge, attitudes, practices, and burden during the COVID-19 pandemic in people with Parkinson’s disease in Germany. JCM. 2020;9(6):1643.
  • Alnajashi H, Jabbad R. Behavioral practices of patients with multiple sclerosis during covid-19 pandemic. PLOS One. 2020;15(10):e0241103.
  • Zhao J, Wang Y, Fisher M, et al. Slower recovery of outpatient clinics than inpatient services for stroke and other neurological diseases after COVID-19 Pandemic. CNS Neurosci Ther. 2020;26(12):1322–1326.
  • Andrews JA, Berry JD, Baloh RH, et al. Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: challenges and opportunities. Muscle Nerve. 2020;62(2):182–186.
  • Cheong JLY, Goh ZHK, Marras C, et al. The impact of COVID-19 on access to Parkinson's disease medication. Mov Disord. 2020;35(12):2129–2133.
  • Chiaravalloti ND, Amato MP, Brichetto G, et al. The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis. J Neurol. 2021;268(5):1598–1607.
  • Sylaja PN, Srivastava MP, Shah S, et al. The SARS‐CoV‐2/COVID‐19 pandemic and challenges in stroke care in India. Ann NY Acad Sci. 2020;1473(1):3–10.
  • Schirinzi T, Di Lazzaro G, Salimei C, et al. Physical activity changes and correlate effects in patients with Parkinson's disease during COVID‐19 lockdown. Mov Disord Clin Pract. 2020;7(7):797–802.
  • Braun V, Clarke V. Using thematic analysis in psychology. Quant Res Psychol. 2006;3(2):77–101.
  • World Bank Country and Lending Groups –World Bank Data Help Desk [Internet]. Datahelpdesk.worldbank.org. 2021; [cited 2 Oct 2021]. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519.
  • Simms A, Fear NT, Greenberg N. The impact of having inadequate safety equipment on mental health. Occup Med. 2020;70(4):278–281.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.